I want to tell you about one of the most compelling health technology startups I've recently invested in to help diversify my portfolio: **rHealth, Inc.** Led by a Harvard and MIT trained physician and technologist, this company is working on something that could completely redefine how we manage our health.
Their breakthrough invention is a handheld device capable of running a full, lab-quality blood panel from just a single drop of blood in under two minutes.
Real-Time Health Information, Anywhere
This could be a true revolution in healthcare. I have long believed that the future of personal health lies in having real-time, personalized information about our own bodies—rather than relying solely on generalized research studies—to make daily health decisions. With this device, you will know exactly what is going on inside your body and can respond with the right steps in real-time, all without ever leaving your house, office, or travel location.
The process is incredibly simple: a quick fingerstick, a device about the size of a small water bottle, and comprehensive results displayed on your mobile screen in minutes. Plus, your doctor can view the information instantly too, enabling seamless remote care.
From the Space Program to Your Pharmacy
This technology wasn't just built in a standard lab. It was originally developed for the Space Program so that astronauts could monitor their health and vitals in real-time while traveling far from any physician or hospital.
To bring this space-grade tech into reality, rHealth has secured 17 patents and raised over **USD 23 million** in capital. The founder envisions a future where these devices will be available at every pharmacy, immediate care center, and residential care facility—becoming an expected standard of convenience for the public before eventually transitioning into nearly every household.
“Imagine caregivers in rural areas getting lab-quality results right at the patient's bedside without having to send samples away. That is the kind of global impact rHealth is building.” — Mark Perlmutter
What's Next for rHealth?
With its solid IP foundation and significant early backing, rHealth's next major steps include navigating the FDA approval process, completing clinical validation, and setting up mass production to make the device accessible to everyone through traditional health coverage.
This is exactly the kind of highly innovative, early-stage company that we love sourcing for our community members.
Mark Perlmutter
Founder, Planet Positive Investing
Past Opportunity: The Round is Closed
rHealth's equity crowdfunding round is now closed. Because the window has shut, investments are no longer open for this particular round. However, at Planet Positive Investing, we are constantly sourcing new, exciting, and sustainable startups to share with our members.
If you don't want to miss future alerts and early-bird access to planet-positive opportunities, make sure to sign up for our club.
Don't Miss the Next Planet-Positive Alert
The rHealth crowdfunding round is now closed. Join 30,450+ members today to receive free alerts as soon as the next high-quality sustainable startups open their investment rounds to the public.
Join Free — Get Crowdfund Alerts